Editorial Comment from Dr Chapple to Long-term safety and efficacy of the novel β3-adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 25
(7)
◽
pp. 668-675
◽
Keyword(s):
2015 ◽
Vol 9
(1)
◽
pp. 38-45
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 18
(9)
◽
pp. 925-929
◽
Keyword(s):
2008 ◽
Vol 15
(11)
◽
pp. 986-991
◽
2018 ◽
Vol Volume 11
◽
pp. 1391-1403
◽
Keyword(s):